Document Detail


Drug development status for Alzheimer's disease: present scenario.
MedLine Citation:
PMID:  23392897     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Recent advances in the understanding of Alzheimer's disease pathogenesis have led to the development of numerous compounds that might ameliorate the disease process. Research in the field of Alzheimer's disease therapy has been partly successful in terms of developing symptomatic treatments, but also had several failures in terms of developing disease-modifying therapies. These successes and failures have led to a debate about the potential deficiencies in our understanding of the pathogenesis of Alzheimer's disease and potential pitfalls in diagnosis, choice of therapeutic targets, development of drug candidates, and design of clinical trials. Many clinical and experimental studies are ongoing, but we need to acknowledge that a single cure for Alzheimer's disease is unlikely to be found and that the approach to drug development for this disorder needs to be reconsidered. Preclinical research is constantly providing us with new information on pieces of the complex Alzheimer's disease puzzle, and an analysis of this information might reveal patterns of pharmacological interactions instead of single potential drug targets. Several promising randomized controlled trials are ongoing, and the increased collaboration between pharmaceutical companies, basic researchers, and clinical researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of Alzheimer's disease.
Authors:
Shubham Misra; Bikash Medhi
Related Documents :
23557837 - High prevalence of behçet's disease in southern italy.
24691487 - Towards the disease biomarker in an individual patient using statistical health monitor...
21279517 - Comorbidity profile of poliomyelitis survivors in a chinese population: a population-ba...
24155907 - Potential use of school absenteeism record for disease surveillance in developing count...
20570207 - The cause of death in idiopathic parkinson's disease.
12955797 - Primary prevention in cardiovascular disease: moving out of the shadows of the truth ab...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-8
Journal Detail:
Title:  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology     Volume:  -     ISSN:  1590-3478     ISO Abbreviation:  Neurol. Sci.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100959175     Medline TA:  Neurol Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Taurine enhances the sexual response and mating ability in aged male rats.
Next Document:  Improving thrombolysis for acute ischemic stroke in Lombardia stroke centers.